Risk score for predicting embolism in AF patients on DOACs

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study examines whether a predefined risk score can identify the likelihood of embolic events in adults with atrial fibrillation who are being treated with DOACs. Participants must be at least 18 years old, have a history of atrial fibrillation, and be on a DOAC, with informed consent and ability to complete follow-up for at least 3 months. Patients with valvular AF or mechanical valves are excluded. Data are collected to correlate DOAC therapy with stroke or embolism risk and to evaluate the score's predictive usefulness in this setting. The study is led by Hospital Universitari Vall d'Hebron Research Institute with collaboration from two Barcelona hospitals at present.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient over 18 years of age
* History of AD
* Currently on DOACs.
* Capacity to understand the study procedures and provide informed consent.

Exclusion Criteria:

* Patient with valvular AF (mitral stenosis) or mechanical valve prostheses.
* Unable to complete a follow-up period of at least 3 months from enrollment.

Where it's running

• Germans Trias University Hospital
  Barcelona, Barcelona, Spain Recruiting
• Vall d'Hebron University Hospital
  Barcelona, Barcelona, Spain Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Post-stroke heart rhythm monitoring with a wearable chest patch in Southern Norway

  This test tries a small wireless chest patch worn up to 14 days to see if it finds atrial fibrillation better than the usual short hospital monitoring in people who recently had an ischemic stroke or TIA.

  Recruiting Sorlandet Hospital HF · Kristiansand · NCT07407790

• Understanding Ischemic Stroke in Patients Taking Blood Thinners

  This study looks at how ischemic strokes affect people taking blood thinners for heart issues to see what helps prevent future strokes.

  Recruiting at 47 sites University of L'Aquila · Zagreb and 46 other locations · NCT06823466

• AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

  This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

  Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

• Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation

  This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.

  Recruiting St. Josefs-Hospital Wiesbaden GmbH · Wiesbaden · NCT07910370

• Pulsed Field Ablation vs Cryoablation for Atrial Fibrillation Under Deep Sedation

  This trial tests whether pulsed field ablation (PFA) done under deep sedation works as well as cryoballoon ablation for treating atrial fibrillation, aiming to avoid general anesthesia.

  Recruiting East Sussex Healthcare NHS Trust · Eastbourne · NCT07900685

• Bachmann’s Bundle Pacing vs Right Atrial Appendage Pacing for AF

  This study tests two common atrial pacing methods to see which one is safer over 12 months for people getting a new pacemaker, ICD, or CRT device.

  Recruiting Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Pittsburgh, Pennsylvania · NCT07874763

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.